Indeterminate Colitis - Update on Treatment Options
- PMID: 34876831
- PMCID: PMC8643196
- DOI: 10.2147/JIR.S268262
Indeterminate Colitis - Update on Treatment Options
Abstract
Indeterminate colitis (IC) is described in approximately 5-15% of patients with inflammatory bowel disease (IBD). It usually reflects a difficulty or lack of clarity in distinguishing between ulcerative colitis (UC) and Crohn's disease (CD) on biopsy or colectomy specimens. The diagnostic difficulty may explain the variability in the reported prevalence and incidence of IC. Clinically, most IC patients tend to evolve over time to a definite diagnosis of either UC or CD. IC has also been interchangeably described as inflammatory bowel disease unclassified (IBDU). This review offers an overview of the available limited literature on the conventional medical and surgical treatments for IC. In contrast to the numerous studies on the medical management of UC and CD, there are very few data from dedicated controlled trials on the treatment of IC. The natural evolution of IC more closely mimics UC. Regarding medical options for treatment, most patients diagnosed with IC are treated similarly to UC, and treatment choices are based on disease severity. Others are managed similarly to CD if there are features suggestive of CD, including fissures, skin tags, or rectal sparing. In medically refractory IC, surgical treatment options are limited and include total proctocolectomy (TPC) and ileal pouch-anal anastomosis (IPAA), with its associated risk factors and complications. Post-surgical complications and pouch failure rates were historically thought to be more common in IC patients, but recent meta-analyses reveal similar rates between UC and IC patients. Future therapies in IBD are focused on known mechanisms in the disease pathways of UC and CD. Owing to the lack of IC-specific studies, clinicians have traditionally and historically extrapolated the data to IC patients based on their symptomatology, clinical course, and endoscopic findings.
Keywords: Crohn’s disease; ileal pouch–anal anastomosis; indeterminate colitis; medical treatment; total proctocolectomy; ulcerative colitis.
© 2021 Venkateswaran et al.
Conflict of interest statement
The authors report no relevant conflicts of interest related to this review.
Similar articles
-
The MYTHS of De novo Crohn's Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis.Jpn J Gastroenterol Hepatol. 2020;3(2):1166. Epub 2020 Mar 11. Jpn J Gastroenterol Hepatol. 2020. PMID: 37584007 Free PMC article.
-
Outcome of Ileal Pouch-anal Anastomosis in Patients With Indeterminate Colitis: A Systematic Review and Meta-analysis.J Crohns Colitis. 2020 Jul 30;14(7):1010-1020. doi: 10.1093/ecco-jcc/jjaa002. J Crohns Colitis. 2020. PMID: 31912129
-
Pathology of indeterminate colitis.J Clin Gastroenterol. 2004 May-Jun;38(5 Suppl 1):S36-40. doi: 10.1097/01.mcg.0000127686.69276.5b. J Clin Gastroenterol. 2004. PMID: 15115930
-
De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry.Am Surg. 2016 Oct;82(10):977-981. Am Surg. 2016. PMID: 27779987
-
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505
Cited by
-
Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy.Medicina (Kaunas). 2023 Nov 23;59(12):2064. doi: 10.3390/medicina59122064. Medicina (Kaunas). 2023. PMID: 38138167 Free PMC article.
-
Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies.Am J Physiol Gastrointest Liver Physiol. 2025 Jan 1;328(1):G17-G31. doi: 10.1152/ajpgi.00252.2024. Epub 2024 Nov 5. Am J Physiol Gastrointest Liver Physiol. 2025. PMID: 39499254 Review.
-
Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond.Diagnostics (Basel). 2024 Jun 28;14(13):1384. doi: 10.3390/diagnostics14131384. Diagnostics (Basel). 2024. PMID: 39001273 Free PMC article. Review.
-
Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.Front Immunol. 2024 Mar 6;15:1353402. doi: 10.3389/fimmu.2024.1353402. eCollection 2024. Front Immunol. 2024. PMID: 38510241 Free PMC article.
-
Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease.J Crohns Colitis. 2023 Mar 18;17(2):185-198. doi: 10.1093/ecco-jcc/jjac119. J Crohns Colitis. 2023. PMID: 35998097 Free PMC article.
References
-
- Meucci G, Bortoli A, Riccioli FA, et al. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur J Gastroenterol Hepatol. 1999;11(8):909–913. doi:10.1097/00042737-199908000-00018 - DOI - PubMed
-
- Kent TH, Ammon RK, DenBesten L. Differentiation of ulcerative colitis and regional enteritis of colon. Arch Pathol. 1970;89(1):20–29. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources